Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Johnson Controls Second Quarter Performance Comparison

Elaine Mendonca by Elaine Mendonca
January 30, 2024
in Breaking News
0
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Johnson Controls is projecting that its second-quarter organic revenue will remain relatively unchanged compared to the previous year. The company also expects its adjusted earnings per share (EPS) before special items to be in the range of $0.74 to $0.78, slightly lower than the estimated $0.78.

During the first quarter of 2024, Johnson Controls reported an adjusted EPS of $0.51, which met market expectations. This indicates a steady performance in line with projections.

In the second quarter of 2023, the company experienced a significant 13% growth in organic sales and a 19% increase in adjusted EPS, reaching $0.75. This demonstrates a strong performance compared to the previous year.

Considering the company’s performance in the corresponding quarters of 2024 and 2023, it provides valuable context for understanding its expectations for the second quarter of this year.

Johnson Controls International plc (JCI) Stock Prices Show Mixed Performance on January 30, 2024: Conduct Thorough Research and Analysis Before Investing

On January 30, 2024, Johnson Controls International plc (JCI) experienced a mixed performance in its stock prices. As of that date, JCI was trading in the middle of its 52-week range, indicating stability. However, it was below its 200-day simple moving average, suggesting a bearish sentiment. The price of JCI shares increased by $0.06 since the market last closed, representing a rise of 0.11%. The stock closed at $56.65. In pre-market trading, JCI experienced a drop of $1.24 in its stock price. Investors should conduct thorough research and analysis before making any investment decisions regarding JCI or any other stock.

JCI Stock Performance on January 30, 2024: Mixed Revenue Growth and Earnings Decline Analysis

Title: JCI Stock Performance on January 30, 2024: A Mixed Bag of Revenue Growth and Earnings Decline

Introduction:

On January 30, 2024, Johnson Controls International (JCI) witnessed a mixed performance in terms of its stock performance. This article will delve into JCI’s financial data, focusing on its revenue growth and earnings decline, to provide insights into the stock’s performance on January 30, 2024.

Total Revenue Growth:

JCI reported a total revenue of $26.79 billion for the past year, representing a 5.91% increase compared to the previous year. However, the total revenue remained flat in the fourth quarter of 2023, standing at $6.91 billion.

Net Income Performance:

JCI recorded a net income of $1.85 billion over the past year, reflecting a significant 20.69% increase compared to the previous year. However, similar to the total revenue, JCI’s net income remained flat in the fourth quarter of 2023, amounting to $549.00 million.

Earnings per Share Decline:

JCI’s EPS for the past year was reported at $2.69, indicating a substantial 22.83% increase compared to the previous year. However, JCI experienced a notable decline in EPS during the fourth quarter of 2023, with the figure dropping to $0.80.

Conclusion:

JCI’s stock performance on January 30, 2024, was characterized by a mixed bag of revenue growth and earnings decline. The lack of growth in the fourth quarter raised concerns among investors. Additionally, the decline in EPS during the same period may have further impacted investor sentiment. Investors and analysts will closely monitor JCI’s future financial reports to gauge the company’s ability to sustain revenue growth and improve its earnings performance.

Tags: JCI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Markets and money

Mixed Analyst Sentiments and Price Targets for SL Green Realty

Biotechnology Market Capitalization

CanFite Expands Licensing Agreement to Include Pancreatic Cancer Indication

Finance_Fiscal (2)

Morgan Stanley Analyst Upgrades Price Target for Regions Financial

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com